Full
Outline
To compare the premature death probability and disease burden of major chronic diseases along with their changing trends among residents in chronic disease comprehensive control and prevention demonstration areas (demonstration areas) and non-demonstration areas in Jinan city, thus providing a basis for improving the residents′ health.
Using mortality data from three demonstration areas and three non-demonstration areas in Jinan, 2013 – 2023, we compared and analyzed age-standardized mortality rates (ASMR), premature mortality probability, and standardized years of life lost (YLL) rates of cardiovascular diseases (CVD), malignant tumors, chronic respiratory diseases (CRD), and diabetes mellitus (DM). The changing trends were assessed based on the average annual percentage change (AAPC).
The demonstration areas had higher average ASMR and standardized YLL rates of CVD, malignant tumors, and the four major chronic diseases and lower average ASMR and standardized YLL rates of CRD and DM than the non-demonstration areas. Significant declining trends were observed for the ASMR of CVD (AAPC = –1.33%, 95%CI: –2.21% to –0.46%), malignant tumors (AAPC = –3.33%, 95%CI: –4.47% to –2.18%), CRD (AAPC = –6.69%, 95%CI: –8.29% to –5.07%), and the four major chronic diseases (AAPC = –2.22%, 95%CI: –2.94% to –1.50%) as well as the standardized YLL rates of CVD (AAPC = –1.66%, 95%CI: –2.50% to –0.81%), malignant tumors (AAPC = –3.96%, 95%CI: –5.23% to –2.68%), CRD (AAPC = –7.41%, 95%CI: –9.12% to –5.67%), and the four major chronic diseases (AAPC = –2.73%, 95%CI: –3.42% to –2.04%), with greater declines in the demonstration areas. The demonstration areas had higher average annual premature death probabilities of malignant tumors and the four major chronic diseases and lower average annual premature death probabilities of CVD, CRD, and DM than the non-demonstration areas. Reductions in premature death probability were observed for CVD (AAPC = –1.70%, 95%CI: –2.57% to –0.82%), malignant tumors (AAPC = –3.60%, 95%CI: –4.80% to –2.39%), CRD (AAPC = –5.81%, 95%CI: –7.90% to –3.68%), and the four major chronic diseases (AAPC = –2.56%, 95%CI: –3.36% to –1.75%), with greater declines in the demonstration areas.
The establishment of demonstration areas in Jinan has significantly reduced premature death burden from CVD, malignant tumors, and CRD. These interventions have shown pronounced benefits for the people aged 30–69. Nevertheless, the prevention and control of DM still need to be strengthened.
105
43
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
